Venous Thromboembolism: Current Insights and Future Directions

Area of Science:

• Cardiovascular Medicine
• Oncology
• Epidemiology

Background:

• Venous thromboembolism (VTE) is a significant global health issue, ranking as the third leading cause of mortality worldwide.
• VTE incidence rates display considerable geographic variation, with Western countries reporting higher rates (1-2 per 1,000 person-years) compared to Eastern countries (<1 per 1,000 person-years).

Purpose of the Study:

• To comprehensively review and synthesize the diverse range of risk factors associated with venous thromboembolism.
• To explore the potential molecular mechanisms underlying VTE development.
• To highlight the differential incidence of VTE across various cancer types.

Main Methods:

• This study is a comprehensive literature review.
• Data was synthesized from existing research on VTE epidemiology and risk factors.
• Focus was placed on identifying common and emerging VTE risk factors and their molecular underpinnings.

Main Results:

• Identified key VTE risk factors include gender, diabetes, obesity, smoking, genetic mutations, hormonal influences, prolonged travel, infections, trauma, and various types of cancer.
• VTE incidence is notably higher in patients with pancreatic, liver, and non-small-cell lung cancers, and lower in those with breast, melanoma, and prostate cancers.
• The review provides insights into the molecular mechanisms contributing to VTE pathogenesis.

Conclusions:

• Understanding the multifaceted risk factors for VTE is crucial for effective prevention and management strategies.
• The association between specific cancers and VTE risk warrants further investigation into targeted therapeutic approaches.
• Further research into the molecular mechanisms of VTE can lead to novel treatment and prevention modalities.